Amanda Natsuhara

Statistics

Publications

Citations

283

H-Index

Active since

2018

Affiliations

University of California, Los Angeles(Current)

Washington University in St. Louis

University of California San Diego

University of Michigan

Moores Cancer Center

Amanda Natsuhara is an author at University of California, Los Angeles specializing in cancer immunotherapy, metastatic squamous cell carcinoma, and medicine.

Publications per year

2018–2021

Publications

Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial

Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden et al. · The Lancet Oncology · 2021 · 258 citations · Full text

Medicine, Oncology, Cancer Pharmacology +10

An open label, nonrandomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of cohort 1 interim analysis.

Assuntina G. Sacco, Ruifeng Chen, Debanjali Ghosh et al. · Journal of Clinical Oncology · 2019 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +17

An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of the interim safety analysis.

Assuntina G. Sacco, Karen Messer, Amanda Natsuhara et al. · Journal of Clinical Oncology · 2018 · 10 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3